Get the Stockscreener App
190.88
0.19%
0.3555
After Hours:
190.71
-0.17
-0.09%
Vaneck Biotech Etf stock is traded at $190.88, with a volume of 3,705.
It is up +0.19% in the last 24 hours and up +0.49% over the past month.
See More
Previous Close:
$190.52
Open:
$191
24h Volume:
3,705
Relative Volume:
0.44
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.25%
1M Performance:
+0.49%
6M Performance:
+20.90%
1Y Performance:
+20.47%
1-Day Range:
$190.63
$191.44
1-Week Range:
$190.20
$193.52
52-Week Range:
$135.34
$200.00
Vaneck Biotech Etf Stock (BBH) Company Profile
Name
Vaneck Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare BBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
190.88 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.85 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.66 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.66 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.53 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
621.26 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Stock (BBH) Latest News
Precious Metals Define Commodity Performance in 2025 - VanEck
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
VanEck ETF TrustVanEck Biotech ETF announces Annual dividend, payable on December 26, 2025 - marketscreener.com
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
AI In Pharma And Biotech: Market Trends 2025 And Beyond - Seeking Alpha
China – Lockdowns, Growth, Policy Options - VanEck
Sentiment Swings and Fundamentals - VanEck
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
Tema Oncology ETF (CANC) Passes $100m AUM, Among Top 3 2025 Healthcare ETFs - Stock Titan
The Global Power Crunch: The New Geopolitical and Economic Frontier - VanEck
Rates and Consequences - VanEck
Gold Responds and Reminds in March - VanEck
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Uncover Big Opportunities in Smaller Companies - VanEck
The Future of Fandom: Why Esports and Gaming Are Outpacing Traditional Sports - VanEck
Investing in Semiconductor ETFs & Stocks - VanEck
SMH ETF: Question & Answer - VanEck
If You’re Reading This Semiconductors & AI Are Taking Over - VanEck
2025 Semiconductor Outlook: Investor Roadmap - VanEck
GDX and GDXJ ETF: Question and Answer - VanEck
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH - Defense World
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
VanEck Mid-November 2025 Bitcoin ChainCheck - VanEck
Vaneck Biotech Etf Stock (BBH) Financials Data
There is no financial data for Vaneck Biotech Etf (BBH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.02%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):